Navigation Links
CytImmune in Medical Technology

CytImmune To Present At ASCO Phase I Clinical Trial of CYT-6091 to be Presented on June 3, 2007

...o 12 noon on June 3. Dr. Lawrence Tamarkin, CEO of cytimmune will present the poster abstract entitled "Prelimi...TNF nanomedicine. "Acceptance to ASCO provides cytimmune the opportunity to present its research to the lea...ology experts," said Dr. Lawrence Tamarkin, CEO of cytimmune Sciences. "For an emerging company, it's a chance ...

CytImmune Presents Positive CYT-6019 Data During the American Society of Clinical Oncology Annual Meeting in Chicago

... data of a National Cancer Institute conducted and cytimmune Sciences sponsored Phase 1 trial of CYT-6091 (Auri...vancing cancer therapy." In preclinical studies, cytimmune achieved safe and targeted delivery of TNF at leve...d the ASCO Poster Presentation can be found on the cytimmune website, (function() { var po = document.createElement('script'); po.type = 'text/javascript'; po.async = true; po.src = ''; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(po, s); })();